Nigeria’s Emzor, Mangalam ink deal to manufacture APIs in Africa

NIGERIA – Emzor pharmaceuticals, a leading manufacturer of medicines in Nigeria, has signed an agreement with India’s Mangalam Drugs & Organics Limited, to locally manufacture and distribute Active Pharmaceutical Ingredients (APIs) for the treatment and prevention of malaria. The arrangement includes an API technology transfer and licensing agreement which establishes a co-development basis for manufacturing APIs for the treatment of malaria which continues to be a leading cause of death on the African continent. This will lead to the development of a world class API manufacturing facility in full compliance…

Read More